BridgeBio Completes Enrollment of Fortify, Phase 3 Registrational Study of Bbp-418 in Limb-Girdle Muscular Dystrophy Type 2I/R9 (Lgmd2I/R9)
BridgeBio完成Bbp-418在肢體帶狀肌肉萎縮症2I/R9(Lgmd2I/R9)的Fortify第3期註冊研究招募。
BridgeBio Completes Enrollment of Fortify, Phase 3 Registrational Study of Bbp-418 in Limb-Girdle Muscular Dystrophy Type 2I/R9 (Lgmd2I/R9)
BridgeBio完成Bbp-418在肢體帶狀肌肉萎縮症2I/R9(Lgmd2I/R9)的Fortify第3期註冊研究招募。
譯文內容由第三人軟體翻譯。